SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors

Preexisting immunity cross-reactive to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in SARS-CoV-1 survivors suggests that a coronavirus disease 2019 vaccine may boost such preexisting cross-reactive memory T cells. We measure SARS-CoV-2 and SARS-CoV-1 spike-specific neutralizing anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Li-Jun, Cui, Xiao-Ming, Zhu, Ka-Li, Yao, Lin, Wang, Guo-Lin, Cao, Wu-Chun, Ma, Mai-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371981/
https://www.ncbi.nlm.nih.gov/pubmed/35987196
http://dx.doi.org/10.1016/j.celrep.2022.111284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371981/
https://www.ncbi.nlm.nih.gov/pubmed/35987196
http://dx.doi.org/10.1016/j.celrep.2022.111284

Ejemplares similares